Aminopeptidase activities in breast cancer tissue

Clinical Chemistry

Volumn 45, Issue 10, 1999, Pages 1797-1802

  Martínez, José M ^a   Prieto, Isabel ^a   Ramírez, María J ^a   Cueva, Cristobal ^b   Alba, Francisco ^c   Ramírez, Manuel ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b Hosp Univ Ciudad de Jaén   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 OXOPROLYL PEPTIDASE; AMINOPEPTIDASE; AMINOPEPTIDASE B; CATHEPSIN; CYSTYL AMINOPEPTIDASE; GLUTAMYL AMINOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN TISSUE;

EID: 0032830553     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.10.1797     Document Type: Article

References (39)

1. 1. Sloane BF, Rozhin J, Moin K, Ziegler G, Fong D, Muschel RJ. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts. Biol Chem 1992;373:589-94.
2. 2. Rochefort H, Biological and clinical significance of cathepsin D in breast cancer. Acta Oncol 1992;31:125-30.
3. 3. Vignon F, Capony F, Chambon M, Freiss G, Garcia M, Rochefort H. Autocrine growth stimulation of the MCF7 breast cancer cells by the estrogen-regulated 52K protein. Endocrinology 1986;118:1537-40.
4. 4. Sanderink GJ, Artur Y, Siest G. Human aminopeptidases: a review of the literature. J Clin Chem Clin Biochem 1988;26:795-807.
5. 5. Sanderink GJ, Artur Y, Schiele F, Gueguen R, Siest G. Alanine aminopeptidase in serum: biological variations and reference limits. Clin Chem 1988;34:1422-6.
6. 6. Mahoney KH, Miller BE, Heppner GH. FACS quantitation of leucine aminopeptidase acid phosphatase on tumor-associated macrophages from metastatic and nonmetastatic mouse mammary tumors. J Leuk Biol 1985;38:573-85.
7. 7. McDonald JK, Barret AJ, eds. Mammalian proteases: a glossary and bibliography. London: Academic Press, 1986:48-55.
8. 8. Martinez JM, Prieto I, Ramirez MJ, De Gasparo M, Hermoso F, Arias JM, et al. Sex differences and age-related changes in human serum aminopeptidase A activity. Clin Chim Acta 1998;274:53-61.
9. 9. Alba F, Arenas JC, López MA. Properties of rat brain dipeptidyl aminopeptidases in the presence of detergents. Peptides 1995;16:325-9.
10. 14 mole. Biochem Biophys Res Commun 1962;9:430-5.
11. 11. Schwabe C, McDonald JK. Demonstration of a pyroglutamyl residue at the N terminus of the B-chain of porcine relaxin. Biochem Biophys Res Commun 1977;74:1501-4.
12. 12. Cheung HS, Cushman DW. A soluble aspartate aminopeptidase from dog kidney. Biochim Biophys Acta 1971;242:190-3.
13. 13. Tobe H, Kojima F, Aoyagi T, Umezawa, H. Purification by affinity chromatography using amastatin and properties of aminopeptidase A from pig kidney. Biochim Biophys Acta 1980;613:459-68.
14. 14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
15. 15. Tandon AK, Clark GM, Chammes GC, Chirgwin JM, McGuire WL. Cathepsin D and prognosis in breast cancer. N Engl J Med 1990;322:297-302.
16. 16. Hersh LB. Characterization of membrane-bound aminopeptidases from rat brain: identification of the enkephalin-degrading aminopeptidase. J Neurochem 1985;44:1427-35.
17. 17. Ahmad S, Ward PE. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J Pharmacol Exp Ther 1990;252:643-50.
18. 18. Johnson GD, Hersh LB. Studies on the subsite specificity of the rat brain puromycin-sensitive aminopeptidase. Arch Biochem Biophys 1990;276:305-9.
19. 19. McDermott JR, Mantle D, Lawfort B, Gibson AM, Biggins A. Purification and characterization of two soluble Cl-activated arginyl aminopeptidases from human brain and their endopeptidase action on neuropeptides. J Neurochem 1988;50:176-82.
20. 20. Itoh C, Nagamatsu A. An aminopeptidase activity from porcine kidney that hydrolyzes oxytocin and vasopressin: purification and partial characterization. Biochim Biophys Acta 1995;1243:203-8.
21. 1] angiotensin I by a novel aminopeptidase in the rat hypothalamus. Biochem Pharmacol 1994;48:1043-6.
22. 22. Migaud M, Durieux C, Viereck J, Soroca-Lucas E, Fournie-Zaluski MC, Roques BP. The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A. Peptides 1996;17:601-7.
23. 23. Cummins PM, O'Connor B. Bovine brain pyroglutamyl aminopeptidase (type-I): purification and characterisation of a neuropeptide-inactivating peptidase. Int J Biochem Cell Biol 1996;8:883-93.
24. 24. Look AT, Ashum RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Investig 1989;83:1299-307.
25. 25. Dixon J, Kaklamanis L, Turley H, Hickson ID, Leek RD, Harris AL, Gatter KC. Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol 1994;47:43-7.
26. 26. Gupta SK, Aziz M, Khan AA. Serum leucine aminopeptidase estimation: a sensitive prognostic indicator of invasiveness in breast carcinoma. Indian J Pathol Microbiol 1989;32:301-5.
27. 27. Severini G, Gentilini L, Tirelli C. Diagnostic evaluation of alanine aminopeptidase as serum marker for detecting cancer. Cancer Biochem Biophys 1991;12:199-204.
28. 28. De Gasparo M, Bottari S, Levens NR. Characteristics of angiotensin II receptors and their role in cell and organ physiology. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis and management, 2nd ed. New York: Raven Press, 1995:1695-710.
29. 29. Inwang ER, Puddefoot JR, Brown CL, Goode AW, Marsigliante S, Ho MM, et al. Angiotensin II type 1 receptor expression in human breast tissues. Br J Cancer 1997;75:1279-83.
30. 30. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Investig 1993;91:2268-74.
31. 31. Small W Jr, Molteni A, Kim YT, Taylor JM, Chen Z, Ward WF. Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture. Breast Cancer Res Treat 1997;44:217-24.
32. 32. Frame KL, Patton K, Reed MJ, Ghilchik MW, Parish DC. Angiotensin-converting enzyme and enkephalinase in human breast cyst fluid. Br J Cancer 1996;74:807-13.
33. 33. Wilk S, Wilk E, Magnusson RP. Purification, characterization, and cloning of a cytosolic aspartyl aminopeptidase. J Biol Chem 1998;273:15961-70.
34. 34. North WG, Pai S, Friedman A, Yu X, Fay M, Memoli V. Vasopressin gene related products are markers of human breast cancer. Breast Cancer Res Treat 1995;34:229-35.
35. 35. Cassoni P, Sapino A, Negro F, Bussolati G. Oxytocin inhibits proliferation of human breast cancer cell lines. Virchows Arch 1994;425:467-72.
36. 36. Murrell TG. The potential for oxytocin to prevent breast cancer: a hypothesis. Breast Cancer Res Treat 1995;35:225-9.
37. 37. Mort JS, Leduc MS. The combined action of two enzymes in human serum can mimic the activity of cathepsin B. Clin Chim Acta 1984;140:173-82.
38. 38. Kottler ML, Starzec A, Carre MC, Lagarde JP, Martin A, Counis R. The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer. Int J Cancer 1997;71:595-9.
39. 39. Checler F. Neuropeptide-degrading peptidases. In: Parvez SH, Naoi M, Nagatsu T, Parvez S, eds. Methods in neurotransmitter and neuropeptide research. New York: Elsevier, 1993:375-418.